Notice2025-19026
Center for Scientific Review; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 30, 2025
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 187 (Tuesday, September 30, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 187 (Tuesday, September 30, 2025)]
[Notices]
[Page 46902]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-19026]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Center for
Scientific Review Special Emphasis Panel, RFA-AI-24-080 Broad Spectrum
Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33
Clinical Trial Not Allowed). November 14, 2025, 10:00 a.m. to November
14, 2025, 05:00 p.m., National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 which was published in the Federal
Register on September 23, 2025, 90 FR 45775, Doc No. 2025-18347
This meeting is being amended to change the date from November 14,
2025, to December 2, 2025. The meeting is closed to the public.
Dated: September 26, 2025.
Denise M. Santeufemio,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-19026 Filed 9-29-25; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on September 30, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.